University of Leicester
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of Leicester
Deals Shaping The Medical Industry, June 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2016.
Life Science Start-Ups: Tech Transfer Deals, November 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Tech Transfers column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2013.
Deals Of The Week: Academic Drug-Discovery Group’s Work Catching Industry’s Notice
As academic labs fill gaps in discovery work once performed by biopharma companies, Roche is confident that a U.S. consortium of academic drug-discovery units will lead to broader partnerships between industry and academia and within the academy itself. Plus, MedImmune acquires ADC specialist Spirogen and other deals from the past week.
ESC Highlights: Imaging, Hypertension Devices Take Center Stage
This year's European Society of Cardiology Congress drew cardiologists from across the globe to packed sessions. While drug-eluting stent reports were a mixed bag, remote catheter navigation explored new frontiers and emerging hypertension devices were a major draw.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.